Skip to main content
. 2017 Dec 5;12(12):e0187537. doi: 10.1371/journal.pone.0187537

Fig 5. Plots of cumulative ranking probability on impact of bone fracture events (SUCRA).

Fig 5

Note: GLP-1RAs: including all kinds of glucagon-like peptide-1(GLP-1) receptor agonists; SGLT-2: Sodium-Glucose co-Transporter 2; Met: metformin; SU: sulphanylureas; TZD: thiazolidinediones. Ranking: probability of being the best treatment, of being the second best, the third best and so on, among the 11 comparisons. SUCRA: surface under the cumulative ranking curve.